Synthesis and Pharmacology of Halogenated δ-Opiod Selective [DAla2] Deltorphin II Peptide Analogs

Loading...
Thumbnail Image

Embargo Date

Related Collections

Degree type

Discipline

Subject

delta opiod receptor
deltorphin
radioiodination
sandmeyer
Chemicals and Drugs
Neurology
Neuroscience and Neurobiology
Neurosciences

Funder

Grant number

License

Copyright date

Distributor

Related resources

Contributor

Abstract

Deltorphins are naturally occurring peptides produced by the skin of the giant monkey frog (Phyllomedusa bicolor). They are δ-opioid receptor-selective agonists. Herein, we report the design and synthesis of a peptide, Tyr-d-Ala-(pI)Phe-Glu-Ile-Ile-Gly-NH2 3 (GATE3-8), based on the [d-Ala2]deltorphin II template, which is δ-selective in in vitro radioligand binding assays over the μ- and κ-opioid receptors. It is a full agonist in [35S]GTPγS functional assays and analgesic when administered supraspinally to mice. Analgesia of 3 (GATE3-8) is blocked by the selective δ receptor antagonist naltrindole, indicating that the analgesic action of 3 is mediated by the δ-opioid receptor. We have established a radioligand in which 125I is incorporated into 3 (GATE3-8). The radioligand has a KD of 0.1 nM in Chinese hamster ovary (CHO) cells expressing the δ receptor. Additionally, a series of peptides based on 3 (GATE3-8) was synthesized by incorporating various halogens in the para position on the aromatic ring of Phe3. The peptides were characterized for binding affinity at the μ-, δ-, and κ-opioid receptors, which showed a linear correlation between binding affinity and the size of the halogen substituent. These peptides may be interesting tools for probing δ-opioid receptor pharmacology.

Advisor

Date Range for Data Collection (Start Date)

Date Range for Data Collection (End Date)

Digital Object Identifier

Series name and number

Publication date

2015-04-01

Journal title

ACS Chemical Neuroscience

Volume number

Issue number

Publisher

Publisher DOI

Journal Issues

Comments

At the time of this publication, Dr. Katlowitz was affiliated with the Memorial Sloan-Kettering Cancer Center, but Dr. Katlowitz is now affiliated with the Children's Hospital of Philadelphia (CHOP).

Recommended citation

Collection